Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors

Neuropharmacology

Volumn 100, Issue , 2016, Pages 98-105

  Di Filippo, Massimiliano ^a   Tozzi, Alessandro ^a,b   Arcangeli, Sara ^a   De Iure, Antonio ^a   Durante, Valentina ^a   Di Gregorio, Maria ^a   Gardoni, Fabrizio ^c   Calabresi, Paolo ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Glutamate; Interferon; Multiple sclerosis; Neurotransmission; NMDA

Indexed keywords

BETA1A INTERFERON; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; STAT1 PROTEIN; AMPA RECEPTOR; BETA INTERFERON; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; IMMUNOMODULATION; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEUS STRIATUM; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; WHOLE CELL PATCH CLAMP; ACTION POTENTIAL; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECTS; NERVE CELL; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; INTERFERON-BETA; MICE, INBRED C57BL; NEURONS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84942364609     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.06.009     Document Type: Article

References (40)

1. J.I. Alvarez, O. Saint-Laurent, A. Godschalk, S. Terouz, C. Briels, S. Larouche, L. Bourbonniere, C. Larochelle, and A. Prat Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions Neurobiol. Dis. 74 2015 14 24
2. V.M. Anderson, N.C. Fox, and D.H. Miller Magnetic resonance imaging measures of brain atrophy in multiple sclerosis J. Magn. Reson. Imaging 23 2006 605 618
3. P. Calabresi, B. Picconi, A. Tozzi, V. Ghiglieri, and M. Di Filippo Direct and indirect pathways of basal ganglia: a critical reappraisal Nat. Neurosci. 17 2014 1022 1030
4. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
5. D.A. Costello, and M.A. Lynch Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-beta Hippocampus 23 2013 696 707
6. S.J. Coultrap, and K.U. Bayer CaMKII regulation in information processing and storage Trends Neurosci. 35 2012 607 618
7. N. Dafny, B. Prieto-Gomez, W.Q. Dong, and C. Reyes-Vazquez Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex Brain Res. 734 1996 269 274
8. N. Dafny, and P.B. Yang Interferon and the central nervous system Eur. J. Pharmacol. 523 2005 1 15
9. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
10. S. Dhib-Jalbut, and S. Marks Interferon-beta mechanisms of action in multiple sclerosis Neurology 74 Suppl. 1 2010 S17 S24
11. M. Di Filippo, B. Picconi, M. Tantucci, V. Ghiglieri, V. Bagetta, C. Sgobio, A. Tozzi, L. Parnetti, and P. Calabresi Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory Behav. Brain Res. 199 2009 108 118
12. M. Di Filippo, A. Tozzi, M. Tantucci, S. Arcangeli, D. Chiasserini, V. Ghiglieri, A. de Iure, and P. Calabresi Interferon-beta1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence Neurobiol. Dis. 62 2014 387 393
13. D.A. Frank, S. Mahajan, and J. Ritz Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling Nat. Med. 5 1999 444 447
14. F. Gardoni, A. Caputi, M. Cimino, L. Pastorino, F. Cattabeni, and M. Di Luca Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities J. Neurochem. 71 1998 1733 1741
15. F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Di Luca, and P. Calabresi A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia J. Neurosci. 26 2006 2914 2922
16. F. Gardoni, L.H. Schrama, A. Kamal, W.H. Gispen, F. Cattabeni, and M. Di Luca Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor J. Neurosci. 21 2001 1501 1509
17. G. Hadjilambreva, E. Mix, A. Rolfs, J. Muller, and U. Strauss Neuromodulation by a cytokine: interferon-beta differentially augments neocortical neuronal activity and excitability J. Neurophysiol. 93 2005 843 852
18. K.M. Hasan, C. Halphen, A. Kamali, F.M. Nelson, J.S. Wolinsky, and P.A. Narayana Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration J. Magn. Reson. Imaging 29 2009 70 77
19. R.G. Henry, M. Shieh, D.T. Okuda, A. Evangelista, M.L. Gorno-Tempini, and D. Pelletier Regional grey matter atrophy in clinically isolated syndromes at presentation J. Neurol. Neurosurg. Psychiatry 79 2008 1236 1244
20. L.D. Jacobs, R.W. Beck, J.H. Simon, R.P. Kinkel, C.M. Brownscheidle, T.J. Murray, N.A. Simonian, P.J. Slasor, and A.W. Sandrock Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS study group N. Engl. J. Med. 343 2000 898 904
21. C.F. Kessing, and W.R. Tyor Interferon-alpha induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor J. Interferon Cytokine Res. 35 2014 317 324
22. S.J. Lee, Y. Escobedo-Lozoya, E.M. Szatmari, and R. Yasuda Activation of CaMKII in single dendritic spines during long-term potentiation Nature 458 2009 299 304
23. J. Lisman, R. Yasuda, and S. Raghavachari Mechanisms of CaMKII action in long-term potentiation Nat. Rev. Neurosci. 13 2012 169 182
24. V. Mendoza-Fernandez, R.D. Andrew, and C. Barajas-Lopez Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus Brain Res. 885 2000 14 24
25. T. Owens, R. Khorooshi, A. Wlodarczyk, and N. Asgari Interferons in the central nervous system: a few instruments play many tunes Glia 62 2014 339 355
26. W. Pan, W.A. Banks, and A.J. Kastin Permeability of the blood-brain and blood-spinal cord barriers to interferons J. Neuroimmunol. 76 1997 105 111
27. P. Paoletti, C. Bellone, and Q. Zhou NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease Nat. Rev. Neurosci. 14 2013 383 400
28. B. Picconi, F. Gardoni, D. Centonze, D. Mauceri, M.A. Cenci, G. Bernardi, P. Calabresi, and M. Di Luca Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism J. Neurosci. 24 2004 5283 5291
29. L.C. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling Nat. Rev. Immunol. 5 2005 375 386
30. C.L. Raison, A.S. Borisov, M. Majer, D.F. Drake, G. Pagnoni, B.J. Woolwine, G.J. Vogt, B. Massung, and A.H. Miller Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression Biol. Psychiatry 65 2009 296 303
31. O. Reetz, K. Stadler, and U. Strauss Protein kinase C activation mediates interferon-beta-induced neuronal excitability changes in neocortical pyramidal neurons J. Neuroinflammation 11 2014 185
32. C. Reyes-Vazquez, B. Prieto-Gomez, and N. Dafny Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus Neuropharmacology 33 1994 1545 1552
33. C. Reyes-Vazquez, B. Prieto-Gomez, and N. Dafny Interferon modulates central nervous system function Brain Res. 1442 2012 76 89
34. R. Santos, B. Weinstock-Guttman, M. Tamano-Blanco, D. Badgett, R. Zivadinov, T. Justinger, F. Munschauer 3rd, and M. Ramanathan Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies J. Neuroimmunol. 176 2006 125 133
35. A.R. Sas, H. Bimonte-Nelson, C.T. Smothers, J. Woodward, and W.R. Tyor Interferon-alpha causes neuronal dysfunction in encephalitis J. Neurosci. 29 2009 3948 3955
36. M.B. Sattler, I. Demmer, S.K. Williams, K. Maier, D. Merkler, I. Gadjanski, C. Stadelmann, M. Bahr, and R. Diem Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions Exp. Neurol. 201 2006 172 181
37. D.G. Standaert, I.K. Friberg, G.B. Landwehrmeyer, A.B. Young, and J.B. Penney Jr. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat Brain Res. Mol. Brain Res. 64 1999 11 23
38. C. Vastagh, F. Gardoni, V. Bagetta, J. Stanic, E. Zianni, C. Giampa, B. Picconi, P. Calabresi, and M. Di Luca N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons J. Biol. Chem. 287 2012 18103 18114
39. B. Weinstock-Guttman, D. Badgett, K. Patrick, L. Hartrich, R. Santos, D. Hall, M. Baier, J. Feichter, and M. Ramanathan Genomic effects of IFN-beta in multiple sclerosis patients J. Immunol. 171 2003 2694 2702
40. R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, M. Catalan, and M. Zorzon Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy Mult. Scler. 13 2007 490 501